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We propose a revised standardized nomenclature for the proteins common to all retroviruses on the basis of
biological function, enzymatic activity, and/or virion location data. (We do not discuss proteins specific for
subfamilies or only some retroviruses.)
During the past decade, the retrovirus proteins have been
designated by the letter "p" followed by an approximate
molecular weight estimated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis or gel filtration data (1).
original molecular weight estimates for some of the proteins
were inaccurate.
We propose a unified nomenclature for retrovirus proteins
on the basis of known biological function, location in virions,
TABLE 1. Proposed nomenclature for proteins common to all retroviruses
Name of proteina
Virus
MA ?b CA NC PR RT IN SU TM
ASLV p19 plO p27 p12 p15 p68 p32 gp85 gp37
MuLV p15 p12 p30 plO p14 p80 p46 gp7O plSE
Mouse mammary tumor virus plO p21 p27 p14 p13 -' gp52 gp36
Mason-Pfizer monkey viruSd plO p18 p27 p14 gp7O gp22
Bovine leukemia virus p15 p24 p12 p14 gp6O gp30
Human T-cell leukemia virus type I p19 p24 p15 p14 - gp46 gp2l
Equine infectious anemia viruse p15 p26 pll gp9O gp45
Human immunodeficiency virus type I p17 p25 p7 p12 p66 p32 gpl20 gp4l
a Order of proteins is 5' to 3' on the viral genome, from left to right.b ?, The nomenclature is not being changed at this time since protein function has not been elucidated.
c-, Size of the protein has not yet been determined.
d Description of proteins found in Henderson et al. (2) and Sonigo et al. (5).
e Description of proteins found in Stephens et al. (6), Rushlow et al., (4), and Henderson et al. (3).
As more information concerning the general properties of
these proteins has accumulated, this nomenclature has
proven to be cumbersome. This problem is particularly
evident in the discussion of proteins from different retrovirus
species for which proteins of different functions have similar
molecular weights or proteins of similar functions have
different molecular weights. In addition, the availability of
nucleotide and protein sequence data has shown that the
* Corresponding author.
and/or enzymatic activity. The nomenclature will use only
two letters composed of either the first two letters of a single
word or the first letters of a double-word description of the
protein. The two-letter notation is preferred over a three-
letter notation to distinguish the protein names from those
used for genes, i.e., gag, pol, and env. Examples of the
proposed nomenclature for several retroviruses are in Table
1.
The acronyms chosen are: MA, matrix protein; CA,
capsid protein; NC, nucleocapsid protein; PR, protease; RT,
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reverse transcriptase; IN, integration protein; SU, surface
prQtein; and TM, transmembrane protein. A review of the
biochemical and biological properties of the proteins from
which the assignments have been made can be found in
Weiss et al. (7). An example of the use of the new acronyms
follows. The avian sarcoma and leukosis virus (ASLV) p15
protease would be referred to as the ASLV PR, or the
murine leukemia virus (MuLV) plO nucleocapsid protein
would be referred to as the MuLV NC. In cases in which it
is important to indicate the gene origin of a protein, the use
of a superscript is recommended (e.g., PR9'9).
An acronym has not been chosen for the ASLV plO,
MuLV p12, mouse mammary tumor virus p21, or Mason-
Pfizer monkey virus p18 because information about their
virion locations or functions is lacking. It is recommended
that the old nomenclature be used in these cases.
We believe that this system is appropriate to use at this
time because it is based on our increased understanding of
viral functions. Additional advantages are (i) it is simple, (ii)
it avoids confusion in describing the proteins of similar
function in different virus species, and (iii) it is similar to
nomenclature used for other animal viruses.
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